Ryzhov and colleagues provided the first genetic evidence indicating that A2BAR regulates vascular endothelial growth factor (VEGF) production from tumor-infiltrating host immune cells and thereby promotes tumor growth (Ryzhov et al., 2008a). Here, VEGFA is linked to neoplasm.